fig10

CDK4/6 and BET inhibitors synergistically suppress pancreatic tumor growth and epithelial-to-mesenchymal transition by regulating the GSK3β-mediated Wnt/β-catenin pathway

Figure 10. Combined PD-0332991 and JQ1 inhibited tumor growth in vivo. (A) Treatment regimens used in the in vivo study; (B) Xenograft tumors harvested from different groups of nude mice; (C) Body weights of mice in each group; (D) Tumor volume changes in response to treatment. Data are presented as mean ± SEM from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; ns: not significant. SEM: Standard error of the mean.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/